CoChat

The impact of ursodeoxycholic acid on cancer, dysplasia and mortality in ulcerative colitis patients with primary sclerosing cholangitis

WOLF, J. M., RYBICKI, L. A., LASHNER, B. A. · 2005 · Alimentary Pharmacology & Therapeutics
Cited by 130

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Abstract

Summary: Background : Colorectal cancer in primary sclerosing cholangitis patients with ulcerative colitis is mostly right‐sided where concentrations of carcinogenic secondary bile acids are highest. Aim : To investigate whether ursodeoxycholic acid could be chemopreventive for colorectal cancer. Methods : A historical cohort study was performed on primary sclerosing cholangitis patients with ulcerative colitis where the 28 patients (cases) who were treated with ursodeoxycholic acid for at least 6 months (mean 3.4 ± 2.7 years) were compared with the 92 patients (controls) who were not treated with ursodeoxycholic acid. The primary outcomes were colorectal cancer and dysplasia. The secondary outcome was overall mortality. Results : The cumulative incidence of dysplasia or cancer was not significantly different between cases and controls (P = 0.17 by log‐rank test). The adjusted relative risk for cases of developing dysplasia or cancer was 0.59 (95% CI 0.26–1.36). The cumulative mortality was significantly different between groups (P = 0.02 by log‐rank test). The adjusted relative risk for cases of death was 0.44 (95% CI 0.22–0.90). Conclusion : In ulcerative colitis patients with primary sclerosing cholangitis, ursodeoxycholic acid did not reduce the risk of developing cancer or dysplasia. However, ursodeoxycholic acid may reduce mortality.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1365-2036.2005.02650.x

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 130

Metadata

Authors
WOLF, J. M., RYBICKI, L. A., & LASHNER, B. A.
Venue
Alimentary Pharmacology & Therapeutics
Publisher
Wiley
Published
2005-10-14
Volume
22
Issue
9
Pages
783-788
ISSN
  • 0269-2813 (ISSN-L)
  • 1365-2036
OpenAlex
W1998384426
Cited by
130
References
2
FWCI
3.36
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The impact of ursodeoxycholic acid on cancer, dysplasia and mortality in ulcerative colitis patients with primary sclerosing cholangitis. https://app.cochat.ai/papers/10.1111/j.1365-2036.2005.02650.x
The paper
WOLF, J. M., RYBICKI, L. A., & LASHNER, B. A. (2005). The impact of ursodeoxycholic acid on cancer, dysplasia and mortality in ulcerative colitis patients with primary sclerosing cholangitis. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/j.1365-2036.2005.02650.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.